20 research outputs found

    Coexpression Network Analysis in Abdominal and Gluteal Adipose Tissue Reveals Regulatory Genetic Loci for Metabolic Syndrome and Related Phenotypes

    Get PDF
    Metabolic Syndrome (MetS) is highly prevalent and has considerable public health impact, but its underlying genetic factors remain elusive. To identify gene networks involved in MetS, we conducted whole-genome expression and genotype profiling on abdominal (ABD) and gluteal (GLU) adipose tissue, and whole blood (WB), from 29 MetS cases and 44 controls. Co-expression network analysis for each tissue independently identified nine, six, and zero MetS–associated modules of coexpressed genes in ABD, GLU, and WB, respectively. Of 8,992 probesets expressed in ABD or GLU, 685 (7.6%) were expressed in ABD and 51 (0.6%) in GLU only. Differential eigengene network analysis of 8,256 shared probesets detected 22 shared modules with high preservation across adipose depots (DABD-GLU = 0.89), seven of which were associated with MetS (FDR P<0.01). The strongest associated module, significantly enriched for immune response–related processes, contained 94/620 (15%) genes with inter-depot differences. In an independent cohort of 145/141 twins with ABD and WB longitudinal expression data, median variability in ABD due to familiality was greater for MetS–associated versus un-associated modules (ABD: 0.48 versus 0.18, P = 0.08; GLU: 0.54 versus 0.20, P = 7.8×10−4). Cis-eQTL analysis of probesets associated with MetS (FDR P<0.01) and/or inter-depot differences (FDR P<0.01) provided evidence for 32 eQTLs. Corresponding eSNPs were tested for association with MetS–related phenotypes in two GWAS of >100,000 individuals; rs10282458, affecting expression of RARRES2 (encoding chemerin), was associated with body mass index (BMI) (P = 6.0×10−4); and rs2395185, affecting inter-depot differences of HLA-DRB1 expression, was associated with high-density lipoprotein (P = 8.7×10−4) and BMI–adjusted waist-to-hip ratio (P = 2.4×10−4). Since many genes and their interactions influence complex traits such as MetS, integrated analysis of genotypes and coexpression networks across multiple tissues relevant to clinical traits is an efficient strategy to identify novel associations

    Cohort Profile: The Oxford Biobank

    Get PDF
    Major progress has been made over the past decade in the understanding of the genetic background to chronic metabolic disease such as type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (CVD). These disorders show a significant degree of heritability and disease pathogenesis that rely on the combination of a multitude of unfavourable genotypes on which over-nutrition, lack of physical exercise, obesity and smoking augment the phenotype. Currently, the number of common genetic variants robustly associated with CVD and T2D are increasing with the increasing size of discovery cohorts; for CVD, the number now exceeds 50 variants1–3 and for T2D and glycaemic traits, the corresponding number is about 75.4,5 Combining several genome-wide association studies (GWAS) datasets which include information on highly relevant intermediate phenotypes has potentially helped in discovery and replication of several disease loci and identification of novel pathways and pleiotropic genes. However, little is known about the functional consequences of most of the identified gene variants. The use of well-characterized bioresources, in which investigations into intermediate phenotypes can be performed, will be invaluable in order to provide mechanistic insight into these poorly characterized genes and thus promote translational research. To this end the Oxford Biobank (OBB) was set up with the primary goal of establishing a local cohort accessible for genomic translational research. The resource is built to enable studies on physiological consequences of genetic mechanisms of disease. A leading principle has been to seek informed consent from participants to be re-approached for future discrete projects. Therefore, based on the information gathered during a baseline visit, ‘recruit-by-genotype’ (RbG) and ‘recruit-by-phenotype’ (RbP) projects allow for detailed investigations of associations between genotypes and biomarkers, or monitoring of more detailed physiological processes. The OBB serves as a resource for researchers to investigate mechanisms leading to increased T2D and CVD susceptibility and to explore novel therapeutic targets in the prevention and treatment of chronic non-communicable diseases
    corecore